Pat Dorsey's position in Royalty Pharma plc is currently worth $124M. That's 0.89% of their equity portfolio (5th largest holding). The first Royalty Pharma plc trade was made in Q3 2025. Since then Pat Dorsey bought shares one more times and sold shares on one occasions. The stake costed the investor $82.5M, netting the investor a gain of 50% so far.